Definitive Contract W81XWH17C0239

This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services, to Profectus Biosciences, Inc., a small business contractor. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, with a ceiling value of $7,524,330.27 and a period of performance through November 30, 2016. The contract is for the GMP (Good Manufacturing Practice) manufacture of the...

This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Janssen Vaccines & Prevention B.V., a foreign-owned for-profit organization, to produce adenoviral vector vaccines containing Ebola inserts. The contract has a ceiling value of $77,606,315.85 and was awarded on April 13, 2005, with an ultimate completion date of August 8, 2012. The contract type is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The place of...

The International AIDS Vaccine Initiative Inc. (IAVI) was awarded a $166.9 million firm fixed-price definitive contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to advance the development of monovalent vaccines for the prevention of Marburg virus (MARV) and Sudan ebolavirus (SUDV) disease. The vaccines are based on recombinant expression of filovirus glycoproteins and represent critical medical countermeasures against emerging infectious disease threats....

<p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Boston Bioscience Inc. on September 27, 2012. The contract, valued at $35,705.00, is for the delivery of EBOLA GP (Z) CARBOXYL TERMINUS ACID PEPTIDES, 15 AMINO ACIDS IN LENGTH. The contract has a completion date of October 3, 2012 and does not utilize a set-aside designation.</p>

This is a $78,296,147.00 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Merck Sharp &amp; Dohme LLC (Merck) for the development of V920, a vaccine against the Ebola virus using a recombinant vesicular stomatitis virus vector. The contract has an ultimate completion date of September 30, 2024 and does not utilize any set-aside designations. Merck is a prominent pharmaceutical manufacturer...

This contract was awarded by the Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Biomedical Advanced Research &amp; Development Authority (BARDA) to Merck Sharp &amp; Dohme LLC, doing business as Merck, a prominent pharmaceutical manufacturer. The contract is for the procurement of up to 1,000,000 licensed doses of ERVEBO, a vaccine for protection against the Zaire ebolavirus (EBOV), as well as vendor managed inventory (VMI)...

The National Cancer Institute awarded a $3.46 million firm fixed-price delivery order to Mriglobal (doing business as Midwest Research Institute) on September 22, 2025, for the manufacture of clinical-grade Epstein-Barr virus vaccine. The contract, which carries no small business set-aside designation, is scheduled for completion by September 21, 2027, and will be performed at Mriglobal's facilities in Kansas City, Missouri. As a 501(c)(3) not-for-profit research organization with over $110...

This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to the Albert B. Sabin Vaccine Institute, Inc. for the manufacture of the Sabin's Sudan Ebolavirus vaccine. The contract has a period of performance from July 22, 2025 to December 28, 2032 and a ceiling value of $238,381,725.66. It is a Cost Plus Fixed Fee contract, with no set-aside designation. The contract was originally solicited through a Broad Agency Announcement (BAA) from...

This is a delivery order issued against the Homeland Defense and Security Technical Area Tasks (HD TATs) indefinite-delivery indefinite-quantity (IDIQ) contract, which is held by the U.S. Air Force Materiel Command. The $12,284,540.00 contract was awarded to Battelle Memorial Institute, a non-profit research and development organization, to support the Joint Vaccine Acquisitions Program's advanced filovirus vaccine development and continued medical countermeasures research. The contract involves...

<p>This is a firm-fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Alpha Diagnostic International Inc., a woman-owned small business. The order is for the procurement of 12 bulk kits of the AMBIS # 1774444 Human Anti-Zaire Ebola Virus Glycoprotein (GP) IgG ELISA Kit, 96 tests quantitative. The total ceiling value of the award is $69,910.00, with a completion date of June 16, 2016. This award does not have a set-aside designation.</p>